Cargando…
Thrombin Inhibition Reduces the Expression of Brain Inflammation Markers upon Systemic LPS Treatment
Systemic inflammation and brain pathologies are known to be linked. In the periphery, the inflammation and coagulation systems are simultaneously activated upon diseases and infections. Whether this well-established interrelation also counts for neuroinflammation and coagulation factor expression in...
Autores principales: | Shavit Stein, Efrat, Ben Shimon, Marina, Artan Furman, Avital, Golderman, Valery, Chapman, Joab, Maggio, Nicola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029482/ https://www.ncbi.nlm.nih.gov/pubmed/30018633 http://dx.doi.org/10.1155/2018/7692182 |
Ejemplares similares
-
Recovery from trauma induced amnesia correlates with normalization of thrombin activity in the mouse hippocampus
por: Ben Shimon, Marina, et al.
Publicado: (2017) -
Factor VII, EPCR, aPC Modulators: novel treatment for neuroinflammation
por: Golderman, Valery, et al.
Publicado: (2022) -
Protease Activated Receptor 2 (PAR2) Induces Long-Term Depression in the Hippocampus through Transient Receptor Potential Vanilloid 4 (TRPV4)
por: Shavit-Stein, Efrat, et al.
Publicado: (2017) -
The Organophosphate Paraoxon and Its Antidote Obidoxime Inhibit Thrombin Activity and Affect Coagulation In Vitro
por: Golderman, Valery, et al.
Publicado: (2016) -
PARIN5, a Novel Thrombin Receptor Antagonist Modulates a Streptozotocin Mice Model for Diabetic Encephalopathy
por: Golderman, Valery, et al.
Publicado: (2023)